|
| |
| | | 67446 | | 24.03.2020 | | Novo Nordisk Pharma AG | | | | | | | | | | | | | 07.06.20. | | | | 07.06.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Rybelsus 3 mg | Tabletten | Tablets (Semaglutidum 3 mg) | A10BJ06 | CI | | 02 | Rybelsus 7 mg | Tabletten | Tablets (Semaglutidum 7 mg) | A10BJ06 | CI | | 03 | Rybelsus 14 mg | Tabletten | Tablets (Semaglutidum 14 mg) | A10BJ06 | CI |
|
|
|
